Health Care/Hospital

Envirotainer Opens RAP e2 Station in Shanghai

UPPLANDS VASBY, Sweden, Feb. 28, 2019 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, today announced that they are expanding their RAP e2 network in Asia-Pacific by adding Shanghai (PVG), China to the growing list of RAP ...

2019-02-28 16:28 870

WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA

- The second product successfully receiving Breakthrough Therapy Designation that WuXi Biologics has enabled its partner to develop SHANGHAI, Feb. 28, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (Stock code: 2269.HK), a leading global open-access biologics technology platform company offe...

2019-02-28 09:52 852

First Patient Dosed in a Clinical Trial of Tyvyt® (Sintilimab injection) in Combination with IBI305 as First Line Treatment for Patients with Advanced Hepatocellular Carcinoma

SUZHOU, China, Feb. 28, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801) today announced that the first patient has been dosed in ORIENT-32, a trial that evaluates Tyvyt® (generic name: sintilimab injection), a fully human anti-programmed cell death protein 1 (anti-PD-1) mo...

2019-02-28 08:30 3237

INC: Cashews May Have Fewer Calories Than Previously Thought - New Scientific Findings

REUS, Spain, Feb. 27, 2019/PRNewswire/ -- In a human-intervention trial published recently in the journal Nutrients, researchers at the USDA, ARS, Beltsville Human Nutrition Research Center, looked at the available energy content in cashew nuts[1].      (Logo:

2019-02-27 21:11 845

Ping An Good Doctor's Revenue Up by 78.7% Y-o-Y in 2018

HONG KONG, Feb. 27, 2019 /PRNewswire/ -- China's leading one-stop healthcare ecosystem platformPing An Healthcare and Technology Company Limited ("Ping An Good Doctor", or the "Company"; stock code: 01833.HK) is pleased to announce its first annual results since listing, with all of the Company's...

2019-02-27 20:44 6913

Innovent Receives IFR Asia-Pacific IPO of the Year 2018 and IFR Asia Review Hong Kong Equity Issue of the Year 2018 Awards

HONG KONG, Feb. 27, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), today announced that it received the International Finance Review (IFR) Asia-Pacific IPO of the Year 2018 and IFR Asia Review Hong Kong Equity Issue of the Year 2018 awards.

2019-02-27 12:00 1378

Blackford Analysis Commended by Frost & Sullivan for its Visionary Implementation of Platform-based Approaches in the Medical Imaging Space

Its platform streamlines the implementation of multiple solutions, accelerating their deployment from years to weeks SANTA CLARA, California, Feb. 26, 2019 /PRNewswire/ -- Based on its recent analysis of the global market for medical imaging artificial intelligence (AI) marketplace solutions, ...

2019-02-26 22:00 718

Cachet Asset Management to Lead the Latest Round of Funding for ProTom International Holding Company

HONG KONG, Feb. 26, 2019 /PRNewswire/ -- Cachet Asset Management Limited ("CAM") is pleased to announce today that it has been appointed as investment adviser toProTom International Holding Company ("ProTom or the "Company"), the most advanced proton therapy technology company in the world that o...

2019-02-26 19:22 2284

Focusing on Advanced Laboratory Instruments and Equipment, Building an All-around Live-action Space -- 2019 InnoLAB Salon Formally Kicked Off

SHANGHAI, Feb. 26, 2019 /PRNewswire/ -- The InnoLAB Salon this session will be divided into four themes:Intelligent Lab, Chromatography, Particle Sizer Analytical Technology, and New Product Recommendation, and gather government agency, senior industry association, leading pharmaceutical enterpri...

2019-02-26 15:00 815

ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million

SHANGHAI and SEOUL, Feb. 26, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and ABL Bio Corporation ("ABL Bio") (298380.KS), a Sout...

2019-02-26 08:23 1020

Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies

Gracell addresses the issues of complex manufacture and high cost of cellular gene therapeutics SUZHOU and SHANGHAI, China, Feb. 26, 2019 /PRNewswire/ -- Gracell Biotechnologies, Co., Ltd. ("Gracell") announced the completion of its$85 million series B funding today. The financing was led by Tem...

2019-02-26 08:07 1040

Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies

SHANGHAI and SUZHOU, China, Feb. 26, 2019 /PRNewswire/ -- Gracell Biotechnologies, Co., Ltd. ("Gracell") announced the completion of its$85 million series B funding today. The financing was led by Temasek with Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji also partici...

2019-02-26 08:07 1149

Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019

3Q19 Added 23,663 New Subscribers Revenues Up 3.7% YoY to RMB254.2 Million ($37.0 Million)  Operating Income Increased to RMB92.6 Million ($13.5 Million) Conference Call to be Held on February 26, 2019 at 8:00 a.m. ET HONG KONG, Feb. 26, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO...

2019-02-26 05:16 6806

Top 3 Growth Opportunities for Digital Pathology-enabling Technology Companies

Establishment of parallel workflows vital to gain regulatory approvals for the use of artificial intelligence capabilities in digital pathology, finds Frost & Sullivan SANTA CLARA, California, Feb. 26, 2019 /PRNewswire/ -- Over the next decade, there will be a shift indigital pathology and artif...

2019-02-26 03:13 716

Mallinckrodt Announces Extracorporeal Photopheresis (ECP) Research Collaboration Agreement With Transimmune AG

-- Collaboration with experts in photopheresis field expected to further enhance understanding of photopheresis' effect on immune modulation across a range of severe and critical conditions -- -- Agreement includes joint development activities for potential next-generation photopheresis system t...

2019-02-25 22:00 3174

Texas Cardiac Arrhythmia Institute at St. David's Medical Center enrolling patients to test stroke-reducing device

AUSTIN, Texas, Feb. 25, 2019 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute at St. David's Medical Center recently began enrolling patients to participate in the DIAMOND-AF II clinical trial to examine the effectiveness of the DiamondTemp System in treating patients with persistent atrial...

2019-02-25 10:08 982

Partnership in healthcare innovation, active ageing, research and education to help the elderly and their caregivers

SINGAPORE, Feb. 23, 2019 /PRNewswire/ -- The Singapore University of Social Sciences (SUSS) signed two Memoranda of Understanding (MOUs) on February 23 to collaborate on various initiatives to better understand and support the needs of the growing silver generation as well as their caregivers. Th...

2019-02-23 12:00 1540

If you purchased dental supplies or equipment directly from Henry Schein, Patterson, Benco, or Burkhart, an $80 million class action settlement may affect you

PHILADELPHIA, Feb. 22, 2019 /PRNewswire/ -- The following statement is being issued byBerger Montague regarding the Dental Supplies Antitrust Litigation. An $80 million cash Settlement has been reached in a lawsuit known as In re Dental Supplies Antitrust Litigation, No 16-cv-00696 (E.D.N.Y.), ag...

2019-02-22 22:17 2001

Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing

BEIJING, Feb. 22, 2019 /PRNewswire/ -- The Forum for the National Mega Innovation Program in conjunction with the press conference on the launch of Tyvyt® (fully human anti-PD-1 therapeutic monoclonal antibody, generic name: sintilimab injection), hosted by Innovent Biologics, Inc. (Innovent) (HK...

2019-02-22 15:02 1795

PharmaEssentia and AOP Orphan Receive EU Approval of Besremi™ (Ropeginterferon Alfa-2b) for Treatment of Polycythemia Vera (PV) in EU

BURLINGTON, Mass., Feb. 22, 2019 /PRNewswire/ -- PharmaEssentia today announced that the European Commission (EC) has approved Besremi® (ropeginterferon alfa-2b, P1101) as monotherapy in adults for the treatment of polycythaemia vera without symptomatic splenomegaly. The European market authoriza...

2019-02-22 06:13 1905
1 ... 226227228229230231232 ... 403